Form D · Other Real Estate

NexPoint Life Sciences III DST

Dallas, TX · CIK 0002008210

Offering snapshot reported Aug 11, 2026 · SEC filing

Reported sold
$28M
Offering amount: $30.7M
Investors reported
92
Form D · investor count
Minimum accepted
$100K
Reported outside-investor minimum
First sale
Jan 25, 2024
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$14M$28MJan 31, 2024: $148,529.00Jan 31, 2024Feb 21, 2024: $417,406.00Mar 12, 2024: $517,406.00Mar 26, 2024: $1,551,858.00May 21, 2024: $1,946,858.00Jul 10, 2024: $2,913,131.00Aug 12, 2024: $4,023,753.00Sep 26, 2024: $4,198,753.00Oct 16, 2024: $4,789,837.00Nov 6, 2024: $6,566,766.00Dec 17, 2024: $8,610,539.00Jan 22, 2025: $9,565,646.00Jan 29, 2025: $9,865,646.00Apr 18, 2025: $11,537,013.00Aug 6, 2025: $14,150,789.00Jan 13, 2026: $25,178,789.00Aug 11, 2026: $27,965,695.00Aug 11, 2026

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$25,178,789 → $27,965,695
  • Reported investors81 → 92

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Aug 11, 2026Amendment$27,965,695$2,786,906vs Jan 13, 202692SEC filing
Jan 13, 2026Amendment$25,178,789$11,028,000vs Aug 6, 202581SEC filing
Aug 6, 2025Amendment$14,150,789$2,613,776vs Apr 18, 202559SEC filing
Apr 18, 2025Amendment$11,537,013$1,671,367vs Jan 29, 202547SEC filing
Jan 29, 2025Amendment$9,865,646$300,000vs Jan 22, 202541SEC filing
Jan 22, 2025Amendment$9,565,646$955,107vs Dec 17, 202440SEC filing
Dec 17, 2024Amendment$8,610,539$2,043,773vs Nov 6, 202437SEC filing
Nov 6, 2024Amendment$6,566,766$1,776,929vs Oct 16, 202431SEC filing
Oct 16, 2024Amendment$4,789,837$591,084vs Sep 26, 202424SEC filing
Sep 26, 2024Amendment$4,198,753$175,000vs Aug 12, 202421SEC filing
Aug 12, 2024Amendment$4,023,753$1,110,622vs Jul 10, 202419SEC filing
Jul 10, 2024Amendment$2,913,131$966,273vs May 21, 202414SEC filing
May 21, 2024Amendment$1,946,858$395,000vs Mar 26, 202410SEC filing
Mar 26, 2024Amendment$1,551,858$1,034,452vs Mar 12, 20247SEC filing
Mar 12, 2024Amendment$517,406$100,000vs Feb 21, 20244SEC filing
Feb 21, 2024Amendment$417,406$268,877vs Jan 31, 20243SEC filing
Jan 31, 2024Initial$148,529No comparison1SEC filing

Offering details

Securities
Equity, Pooled investment fund
Exemptions
06c, 3C, 3C.1, 3C.5
Duration over one year
No
Business combination
No
Sales commissions
$2.68M (estimated)
Finders' fees
$0 (estimated)
Form D file number
021-503969
Regarding Item 11, the Issuer may accept smaller investments in the Sponsor's sole discretion.
Sales Commissions include estimates of the maximum amount of Selling Commissions and Dealer Fees that may be paid.

Sales compensation recipients

Scroll to see all columns →

RecipientCRDAssociated broker-dealer
Aurora Securities46147
Emerson Equity LLC130032
DFPG Investments, LLC155576
Arkadios Capital282710
Realized Financial, Inc.22333
IBN Financial Services, Inc.42360
Great Point Capital LLC114203
Centaurus Financial, Inc.30833
Creativeone Securities, LLC152974
American Trust Investment Services, Inc.3001
Independent Financial Group, LLC7717
Westpark Capital, Inc.39914
Saxony Securities, Inc.115547
FNEX Capital, LLC166316
Realta Equities, Inc.23769
Alexander Capital, L.P.40077

Source: Form D, filed Aug 11, 2026. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Matt Mc Graner Executive
Brian Mitts Executive
N/A Nex Point Real Estate Advisors Iv, L.P. Executive
N/A Nrea Ls Iii Contributor, Llc Executive
N/A Nrea Ls Iii Manager, Llc Executive

Issuer details

Industry: Other Real Estate (See others in industry)

Address:
300 Crescent Court Suite 700
Dallas, TX, 75201